Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs-Reference-Cited by-同舟云学术

Modeling the prevalence of immunodeficiency-associated long-term vaccine-derived poliovirus excretors and the potential benefits of antiviral drugs

Published:2015-09-17 Issue:1 Volume:15 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Duintjer Tebbens Radboud J.,Pallansch Mark A.,Thompson Kimberly M.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-015-1115-5.pdf

Reference66 articles.

1. World Health Organization: Polio Eradication Initiative. Cessation of Routine Oral Polio Vaccine (OPV) use after Global Polio Eradication. Framework for National Policy Makers in OPV-using Countries. Geneva, 2005; Report No.: WHO/POL/05.02.

2. Duintjer Tebbens RJ, Pallansch MA, Kew OM, Cáceres VM, Jafari H, Cochi SL, et al. Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. Risk Anal. 2006;26(6):1471–505.

3. World Health Organization. Transmission of wild poliovirus type 2—Apparent global interruption. Wkly Epidemiol Rec. 2001;76:95–7.

4. World Health Organization: Global Polio Eradication Initiative: Polio Eradication and Endgame Strategic Plan (2013–2018). Geneva, 2013; Report No.: WHO/POLIO/13.02.

5. Global Polio Eradication Initiative. World ready for OPV2 cessation. http://www.polioeradication.org/mediaroom/newsstories/World-ready-for-OPV2-cessation-/tabid/526/news/1181/Default.aspx?popUp=true . Accessed January 28 2015.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health Economic Analysis of Antiviral Drugs in the Global Polio Eradication Endgame;Medical Decision Making;2023-08-14

2. Looking back at prospective modeling of outbreak response strategies for managing global type 2 oral poliovirus vaccine (OPV2) cessation;Frontiers in Public Health;2023-03-24

3. Poliovirus Vaccine–Live;Plotkin's Vaccines;2023

4. Health economic analysis of vaccine options for the polio eradication endgame: 2022-2036;Expert Review of Vaccines;2022-10-05

5. Poliovirus excretion among children with primary immune deficiency in Pakistan: a pilot surveillance study protocol;BMJ Open;2021-07